N

    Nano X Imaging Ltd (NNOX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.81
    -0.02 (-2.68%)

    Market Cap: $65.20M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(14/25)
    Avg Surprise
    -6.26%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.10 - $-0.10
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.12-20.0%
    60d ago$-0.07+35.0%
    30d ago$-0.11-10.0%
    7d ago$-0.11-10.0%
    Current$-0.10
    Revenue Consensus
    $7M
    Range$6M - $9M
    3 analysts
    Dec 31, 2026
    EPS Consensus$-0.12
    Range$-0.12 - $-0.12
    1 analysts
    Revenue Consensus
    $9M
    Range$5M - $13M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.12---
    Sep 26EST
    		-$-0.10---
    Jun 26
    		$-0.23$-0.12-91.67%Miss-35.3%
    Mar 26
    		$-0.20$-0.14-42.86%Miss-33.3%
    Dec 25
    		$-0.17$-0.15-13.33%Miss+0.0%
    Sep 25
    		$-0.15$-0.17+11.76%Beat+0.0%
    Jun 25
    		$-0.17$-0.15-13.33%Miss-21.4%
    Mar 25
    		$-0.15$-0.15+0.00%Beat+28.6%
    Dec 24
    		$-0.17$-0.15-13.33%Miss+5.6%
    Sep 24
    		$-0.15$-0.15+0.00%Beat+59.5%
    Jun 24
    		$-0.14$-0.15+6.67%Beat+54.8%
    Mar 24
    		$-0.21$-0.26+19.23%Beat+0.0%
    Dec 23
    		$-0.18$-0.30+40.00%Beat+79.1%
    Sep 23
    		$-0.37$-0.30-23.33%Miss+0.0%
    Jun 23
    		$-0.31$-0.26-19.23%Miss+18.4%
    Mar 23
    		$-0.21$-0.34+38.24%Beat+48.8%
    Dec 22
    		$-0.86$-0.43-100.00%Miss-91.1%
    Sep 22
    		$-0.37$-0.42+11.90%Beat-32.1%
    Jun 22
    		$-0.38$-0.25-52.00%Miss-111.1%
    Mar 22
    		$-0.41$-0.22-86.36%Miss-173.3%
    Dec 21
    		$-0.45$-0.33-36.36%Miss-150.0%
    Sep 21
    		$-0.28$-0.28+0.00%Beat-115.4%
    Jun 21
    		$-0.18$-0.20+10.00%Beat-800.0%
    Mar 21
    		$-0.15$-0.27+44.44%Beat+70.6%
    Dec 20
    		$-0.18$-0.20+10.00%Beat-
    Sep 20
    		$-0.13N/A+51.85%Beat-
    Jun 20
    		$-0.02N/A+91.30%Beat-
    Dec 19
    		$-0.51$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.08EV/EBITDA-7.41x
    Price/FCF-1.10xFCF Yield-90.85%
    Profitability
    Profit Margin0.00%Operating Margin-337.00%
    ROE-50.10%ROIC-45.76%
    Financial Health
    Debt/Equity0.02xInterest CoverageN/A
    Current Ratio3.64xQuick Ratio3.40x
    Trading Statistics
    Beta1.27Avg Volume1.08M
    52-Week High$4.7152-Week Low$0.73

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.86
    SMA 20$0.95
    SMA 50$1.05
    SMA 200$2.18
    EMA 10$0.87
    EMA 20$0.92
    EMA 50$1.11
    EMA 200$2.14

    MACD

    Line: -0.07Signal: -0.07Hist: -0.00

    ADX

    ADX: 25.5+DI: 11.6-DI: 26.4

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down100.0
    PSAR$1.05

    Bollinger Bands

    Upper Band$1.13
    Lower Band$0.76
    %B Position3938%(Upper)
    Band Width0.13

    RSI (14-Day)

    Neutral
    33.7

    Momentum Oscillators

    Stoch %K7.0
    Stoch %D8.2
    Williams %R-90.9
    ROC (10d)-13.5%
    Momentum-0.13
    CCI (20d)-124.1
    MFI (14d)12.7

    Volatility Measures

    ATR (14d)$0.08(10.0%)
    StdDev (20d)0.09
    Hist Vol60.0%(High)

    Volume Flow

    VWAP$0.80
    OBV-44.4M
    AD Line-50.7M
    CMF (20d)-0.313

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.3x
    VWMA (20d)$0.96

    Pivot Points

    R3$0.95
    R2$0.92
    R1$0.87
    Pivot Point$0.84
    S1$0.79
    S2$0.76
    S3$0.71

    Advanced Oscillators

    TSI-24.12
    Ultimate Osc33.2
    KST-155.96

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$4.31M$3.72M$3.45M$3.04M$2.81M$3.00M$3.03M$2.70M$2.55M$2.40M$2.48M$2.58M
    Cost of Revenue$7.01M$7.63M$6.33M$6.28M$5.86M$5.89M$5.84M$5.55M$4.70M$4.11M$4.14M$4.27M
    Gross Profit$-2,698,000$-3,913,000$-2,882,000$-3,240,000$-3,049,000$-2,890,000$-2,812,000$-2,853,000$-2,151,000$-1,716,000$-1,662,000$-1,691,000
    Operating Expenses$12.09M$12.55M$11.35M$11.25M$11.04M$17.98M$11.33M$11.46M$10.93M$11.54M$12.89M$16.00M
    R&D$4.84M$4.84M$4.59M$4.83M$4.98M$5.40M$4.75M$4.81M$5.22M$6.81M$6.04M$6.91M
    SG&A$5.24M$7.89M$5.28M$5.13M$5.14M$6.56M$5.71M$5.92M$5.04M$5.53M$5.05M$7.63M
    Operating Income$-14,790,000$-16,500,000$-14,235,000$-14,491,000$-14,090,000$-14,975,000$-14,139,000$-14,507,000$-13,084,000$-13,256,000$-21,993,000$-17,831,000
    Interest Income$369,000$351,000$457,000$0$765,000$820,000$404,000$856,000$790,000$360,000$511,000$380,000
    Interest Expense$0$18.57M$0$149,000$0$0$0$0$0$0$0$0
    Income Before Tax$-14,189,000$-35,067,000$-13,778,000$-14,640,000$-13,325,000$-14,155,000$-13,733,000$-13,651,000$-12,335,000$-10,327,000$-21,482,000$-17,451,000
    Income Tax Expense$76,000$-1,694,000$-94,000$82,000$-86,000$0$-94,000$-76,000$-94,000$-79,000$-79,000$-87,000
    Net Income$-14,265,000$-33,372,999$-13,684,000$-14,722,000$-13,239,000$-14,061,000$-13,639,000$-13,575,000$-12,241,000$-10,248,000$-21,403,000$-17,364,000
    EBITDA$-11,971,000$-14,070,000$-11,277,000$-11,542,000$-11,147,000N/A$-11,208,000$-11,535,000$-10,186,000$-7,571,000$-11,659,000$-14,787,000
    EBIT$-14,790,000$-16,917,000$-14,235,000$-14,491,000$-14,090,000N/A$-14,139,000$-14,463,000$-13,125,000$-10,572,000$-14,556,000$-17,694,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NNOX

    News

    NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

    The Gross Law Firm has issued a shareholder alert for Nano-X Imaging Ltd. (NASDAQ: NNOX), announcing a securities class action lawsuit. The lawsuit alleges that Nano-X Imaging Ltd. made materially false or misleading statements regarding its operational efficiency, product demand, and increased operating expenses, leading to artificial inflation of its stock. Investors who purchased NNOX shares between March 31, 2025, and April 17, 2026, are encouraged to contact the firm, with a lead plaintiff deadline of August 11, 2026.

    Eastern Progress•8/22/26•
    Bearish

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX

    Pomerantz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. (NNOX) on behalf of its investors. This investigation follows Nano-X's announcement of a $33.4 million net loss for Q4 2025, primarily due to a $17.5 million impairment charge related to a restructuring at its Korean chip manufacturing facility. Additionally, the company announced that its CFO would be stepping down, leading to a 24.39% drop in Nano-X's stock price.

    Eastern Progress•8/22/26•
    Bearish

    NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit

    The Rosen Law Firm is reminding investors of Nano-X Imaging Ltd. (NASDAQ: NNOX) who purchased securities between March 31, 2025, and April 17, 2026, about the August 11, 2026 lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Nano-X made false and misleading statements regarding operational efficiency, demand for its products, and increased operating expenses, leading to investor damages. Investors are encouraged to contact the Rosen Law Firm to join the class action.

    Eastern Progress•8/21/26•
    Bearish

    Nanox AI secures UK reseller deal for bone health software

    Nanox AI, a subsidiary of Nanox Imaging Ltd., has entered into an exclusive three-year reseller agreement with Vertec Scientific Ltd. for its HealthOST bone solution in the UK. HealthOST is an FDA-cleared and UKCA/CE-marked AI software that analyzes routine CT scans to assess musculoskeletal disease of the spine, including osteoporosis, without requiring additional imaging or patient time. This deal aims to expand the reach of Nanox AI's technology in the UK market, following a recommendation by the National Institute for Health and Care Excellence for similar AI technologies in opportunistic detection of vertebral fragility fractures.

    Investing.com•8/18/26•
    Bullish

    Nanox and Vertec Scientific Enter Exclusive Sales Reseller

    Nanox AI has partnered with Vertec Scientific Ltd. through an exclusive sales reseller agreement to commercialize its Nanox.AI bone solution (HealthOST) in the United Kingdom. This three-year agreement includes minimum annual license commitments and aims to expand the reach of AI-driven bone health assessment. HealthOST is an FDA-cleared and UKCA/CE-marked AI software that analyzes routine CT scans to detect musculoskeletal diseases like osteoporosis.

    GlobeNewswire•8/18/26•
    Bullish

    Frequently Asked Questions About NNOX

    Does NNOX pay dividends?
    Nano X Imaging Ltd (NNOX) does not currently pay a regular dividend.
    What is NNOX's market cap?
    Nano X Imaging Ltd (NNOX) has a market capitalization of $65.20M with a current stock price of $0.81.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In